| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1132fb7f604ffacaf15a7d01d25994b1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-59 |
| filingDate |
2017-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d8efb718d9eede73ae7a9ee81420d2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c123f3122cd8be52bc974d75b65972ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12092dc9b47cddf33149804ba129d35f |
| publicationDate |
2019-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2019006670-A |
| titleOfInvention |
COMPOSITIONS THAT INCLUDE METHYLPHENIDATE PRO-DRUGS, PROCEDURES FOR THE PREPARATION AND USE OF THE SAME. |
| abstract |
The present technology is directed at compositions comprising conjugates of d-threomethylphenidate and unconjugated methylphenidate. The present technology also relates to oral compositions and formulations comprising d-threomethylphenidate conjugated to nicotinoyl-L-serine, and / or a pharmaceutically acceptable salt thereof, and unconjugated methylphenidate and / or a pharmaceutically acceptable salt thereof. The present technology additionally relates to a pharmaceutical kit containing the composition comprising d-threo-methylphenidate conjugated to nicotinoyl-L-serine, and / or a pharmaceutically acceptable salt thereof, and unconjugated methylphenidate and / or a salt. pharmaceutically acceptable thereof. |
| priorityDate |
2016-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |